Literature DB >> 14629727

Identification and functional validation of a 5' upstream regulatory sequence in the human tyrosinase gene homologous to the locus control region of the mouse tyrosinase gene.

Lucía Regales1, Patricia Giraldo, Angel García-Díaz, Alfonso Lavado, Lluís Montoliu.   

Abstract

Comparison analysis of the sequences of the mouse and human genomes has proven a powerful approach in identifying functional regulatory elements within the non-coding regions that are conserved through evolution between homologous mammalian loci. Here, we applied computational analysis to identify regions of homology in the 5' upstream sequences of the human tyrosinase gene, similar to the locus control region (LCR) of the mouse tyrosinase gene, located at -15 kb. We detected several stretches of homology within the first 30 kb 5' tyrosinase gene upstream sequences of both species that include the proximal promoter sequences, the genomic region surrounding the mouse LCR, and further upstream segments. We cloned and sequenced a 5' upstream regulatory sequence found between -8 and -10 kb of the human tyrosinase locus (termed h5'URS) homologous to the mouse LCR sequences, and confirmed the presence of putative binding sites at -9 kb, homologous to those described in the mouse tyrosinase LCR core. Finally, we functionally validated the presence of a tissue-specific enhancer in the h5'URS by transient transfection analysis in human and mouse cells, as compared with homologous DNA sequences from the mouse tyrosinase locus. Future experiments in cells and transgenic animals will help us to understand the in vivo relevance of this newly described h5'URS sequence as a potentially important regulatory element for the correct expression of the human tyrosinase gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14629727     DOI: 10.1046/j.1600-0749.2003.00100.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  8 in total

1.  The Tyr (albino) locus of the laboratory mouse.

Authors:  Friedrich Beermann; Seth J Orlow; M Lynn Lamoreux
Journal:  Mamm Genome       Date:  2004-10       Impact factor: 2.957

2.  Clinical evaluation and molecular screening of a large consecutive series of albino patients.

Authors:  Lucia Mauri; Emanuela Manfredini; Alessandra Del Longo; Emanuela Veniani; Manuela Scarcello; Roberta Terrana; Adriano Egidio Radaelli; Donata Calò; Giuseppe Mingoia; Antonella Rossetti; Giovanni Marsico; Marco Mazza; Giovanni Pietro Gesu; Maria Cristina Patrosso; Silvana Penco; Elena Piozzi; Paola Primignani
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

3.  Update on the regulation of mammalian melanocyte function and skin pigmentation.

Authors:  Taisuke Kondo; Vincent J Hearing
Journal:  Expert Rev Dermatol       Date:  2011-02-01

4.  Comprehensive analysis of oculocutaneous albinism among non-Hispanic caucasians shows that OCA1 is the most prevalent OCA type.

Authors:  Saunie M Hutton; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2008-05-08       Impact factor: 8.551

5.  A strategy to study tyrosinase transgenes in mouse melanocytes.

Authors:  Alfonso Lavado; Ander Matheu; Manuel Serrano; Lluís Montoliu
Journal:  BMC Cell Biol       Date:  2005-04-12       Impact factor: 4.241

6.  Functional validation of mouse tyrosinase non-coding regulatory DNA elements by CRISPR-Cas9-mediated mutagenesis.

Authors:  Davide Seruggia; Almudena Fernández; Marta Cantero; Pawel Pelczar; Lluis Montoliu
Journal:  Nucleic Acids Res       Date:  2015-04-20       Impact factor: 16.971

7.  BRAF activation initiates but does not maintain invasive prostate adenocarcinoma.

Authors:  Joseph H Jeong; Zhenxiong Wang; Alexander S Guimaraes; Xuesong Ouyang; Jose L Figueiredo; Zhihu Ding; Shan Jiang; Isil Guney; Gyeong Hoon Kang; Eyoung Shin; William C Hahn; Massimo F Loda; Cory Abate-Shen; Ralph Weissleder; Lynda Chin
Journal:  PLoS One       Date:  2008-12-16       Impact factor: 3.240

8.  Global patterns of diversity and selection in human tyrosinase gene.

Authors:  Georgi Hudjashov; Richard Villems; Toomas Kivisild
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.